Browse
Submit Data
Databases
API
Help

Dataset Information

6 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

(4R,5S)-4-Hy-droxy-meth-yl-5-[(methyl-sulfanyl)-meth-yl]-1,3-oxazolidin-2-one.

ABSTRACT: The title compound, C(6)H(11)NO(3)S, crystallizes utilizing a three-dimensional set of O-H?O, N-H?O and C-H?O hydrogen bonds. The 1,3-oxazolidin-2-one ring adopts an envelope conformation with the C atom bearing the hy-droxy-methyl group as the flap.

SUBMITTER: Gainsford GJ

PROVIDER: S-EPMC3393898 | biostudies-other | 2012 Jul

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Publications

(4R,5S)-4-Hy-droxy-meth-yl-5-[(methyl-sulfanyl)-meth-yl]-1,3-oxazolidin-2-one.

Gainsford Graeme J GJ Clinch Keith K

Acta crystallographica. Section E, Structure reports online 20120613 Pt 7

The title compound, C(6)H(11)NO(3)S, crystallizes utilizing a three-dimensional set of O-H⋯O, N-H⋯O and C-H⋯O hydrogen bonds. The 1,3-oxazolidin-2-one ring adopts an envelope conformation with the C atom bearing the hy-droxy-methyl group as the flap. ...[more]

PMID: 22798763

Similar Datasets

(E)-3-[(2-Hy-droxy-naphthalen-1-yl)methyl-idene-amino]-5-(morpholin-4-yl-meth-yl)-1,3-oxazolidin-2-one.

Project description:The title compound, C(19)H(21)N(3)O(4), crystallizes with two independent mol-ecules in the asymmetric unit. In both mol-ecules, there is an intra-molecular O-H?N hydrogen bond, which correlates with the fact that each mol-ecule adopts an E configuration with respect to the C=N bond. In the crystal, there are C-H?O and C-H?? inter-actions present.

| S-EPMC3151765 | biostudies-literature

Crystal structure of (4R,5S)-4-methyl-3-methyl-sulfinyl-5-phenyl-1,3-oxazolidin-2-one.

Project description:The absolute structure of the chiral asymmetric indole precursor title compound, C11H13NO3S, was confirmed by refinement of the Flack and Hooft parameters and is that expected based on the starting materials for the synthesis. The phenyl group subtends a dihedral angle of 56.40?(5)° with the mean plane of the oxazolidinone ring, which adopts an envelope conformation, with the C atom bearing the methyl group as the flap. In the crystal, no significant directional inter-actions beyond van der Waals contacts are observed.

| S-EPMC4257383 | biostudies-literature

1,3-Dihy-droxy-2-(hy-droxy-meth-yl)propan-2-aminium formate.

Project description:The title compound, C(4)H(12)NO(3) (+)·CHO(2) (-), was obtained from 1,3-dihy-droxy-2-(hy-droxy-meth-yl)propan-2-aminium acetate and ethyl formate. In the crystal, the cations and anions are held together by inter-molecular N-H?O and O-H?O hydrogen bonds.

| S-EPMC3089189 | biostudies-literature

(4S)-4-[(R)-Chloro-(4-nitro-phen-yl)meth-yl]-1,3-oxazolidin-2-one.

Project description:In the title compound, C10H9ClN2O4, the oxazolidinone ring adopts a near-planar conformation, with mean and maximum deviations of 0.0204?(8) and 0.0328?(8)?Å, respectively. The nitro group is twisted slightly from the plane of the benzene ring, making a dihedral angle of 6.79?(3)°. The dihedral angle between the mean oxazolidinone plane and the benzene ring is 56.21?(3)°. In the crystal, N-H?O hydrogen bonds and N-O?? inter-actions [O?centroid distances = 3.478?(1) and 3.238?(1)?Å] dominate the packing, forming infinite zigzag chains along the b-axis direction. Neighbouring chains are linked together through C-H?O and C-H?Cl inter-actions. The absolute configuration of the two stereogenic centres was determined using the anomalous dispersion of the Cl atom.

| S-EPMC3648307 | biostudies-literature

(4R)-4-Benzyl-3-{(4S)-4-chloro-4-[(S)-2,2-dimethyl-1,3-dioxolan-4-yl]butano-yl}-1,3-oxazolidin-2-one.

Project description:The title compound, C(19)H(24)ClNO(5), was synthesized and subsequently employed in an Evans alkyl-ation. The purpose was to prove the absolute configuration in the projected synthesis of the side chain of (-)-Lytophilippine A. The oxazolidinone and the isopropylidene acetal rings have twisted conformations. The oxazolidinone and side-chain carbonyl groups are orientated in an anti-periplanar arrangement to minimize van der Waals repulsions. Furthermore, the Cl atom and the acetonide-protected secondary alcohol are also in an anti-periplanar arrangement with a torsion angle of 173.64?(14)°. The absolute configuration was determined and agrees with the configuration of the used chiral auxiliary.

| S-EPMC3254509 | biostudies-literature

(5Z)-5-(2-Hy-droxy-benzyl-idene)-3-(4-methyl-phen-yl)-2-sulfanyl-idene-1,3-thia-zolidin-4-one.

Project description:In the title compound, C(17)H(13)NO(2)S(2), the dihedral angles between the 2-sulfanyl-idene-1,3-thia-zolidin-4-one group and the pendant toluene and 2-hy-droxy-benzene rings are 74.62?(6) and 8.73?(12)°, respectively. An intra-molecular C-H?S inter-action occurs. In the crystal, inversion dimers linked by pairs of O-H?O hydrogen bonds generate R(2) (2)(16) loops. This link is reinforced by a pair of C-H?O hydrogen bonds. The dimers are connected by weak C-H?S inter-actions.

| S-EPMC3379392 | biostudies-literature

A new polymorph of 1-({[1,3-dihy-droxy-2-(hy-droxy-meth-yl)propan-2-yl]iminio}meth-yl)naphthalen-2-olate.

Project description:The title compound, C15H17NO4, containing two mol-ecules in the asymmetric unit is a polymorph of the crystal structure published by Martínez et al. [(2011). Eur. J. Org. Chem. pp. 3137-3145] which at 120 K is monoclinic with one mol-ecule in the asymmetric unit. Both mol-ecules in the title compound are in the trans form. In the crystal, N-H⋯O and O-H⋯O hydrogen bonds connect mol-ecules, forming a two-dimensional network parallel to (001).

| S-EPMC4555412 | biostudies-literature

3-Hy-droxy-1-[(morpholin-4-yl)meth-yl]pyridazin-6(1H)-one.

Project description:In the title compound, C9H13N3O3, the morpholine ring adopts a chair conformation and its mean plane makes a dihedral angle of 68.00?(11)° with the pyridazine ring. The carbonyl O atom deviates from the plane of the pyridazine ring by 0.0482?(12)?Å. An intra-molecular C-H?O hydrogen bond occurs. In the crystal, mol-ecules are linked by O-H?O and C-H?O hydrogen bonds, forming chains along [1-10].

| S-EPMC3648302 | biostudies-literature

4-Hy-droxy-3-[(4-hy-droxy-2-oxo-2H-3-chromen-yl)(3-thien-yl)meth-yl]-2H-chromen-2-one.

Project description:The whole mol-ecule of the title compound, C(23)H(14)O(6)S, is disordered over two sets of sites with refined occupancies of 0.8733?(12):0.1267?(12). The dihedral angle between the mean planes through the chromene ring systems is 56.31?(5) and 55.2?(3)° for the major and minor components, respectively. In both components, a pair of intra-molecular O-H?O inter-actions generate rings of S(8) graph-set motif. In the crystal, the mol-ecules are linked by inter-molecular C-H?O inter-actions, forming chains along the b axis. The structure is further stabilized by ?-? inter-actions with centroid-centroid distances of 3.594?(2) and 3.608?(5)?Å.

| S-EPMC3089123 | biostudies-literature

Crystal structure of ethyl 6-(2-fluoro-phen-yl)-4-hy-droxy-2-sulfanyl-idene-4-tri-fluoro-meth-yl-1,3-diazinane-5-carboxyl-ate.

Project description:In the title compound, C14H14F4N2O3S, the central di-hydro-pyrimidine ring adopts a sofa conformation with the C atom bearing the 2-fluoro-benzene ring displaced by 0.596?(3)?Å from the other five atoms. The 2-fluoro-benzene ring is positioned axially and bis-ects the pyrimidine ring with a dihedral angle of 70.92?(8)°. The mol-ecular conformation is stabilized by an intra-molecular O-H?O hydrogen bond, generating an S(6) ring. The crystal structure features C-H?F, N-H?S and N-H?O hydrogen bonds, which link the mol-ecules into a three-dimensional network.

| S-EPMC4420055 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data